0

Journal Articles

in Diabetes Mellitus Type 2
 1-15 of 15 Articles
Correspondence | 
Iman Aouidad, MD; Charlotte Fite, MD; Eduardo Marinho, MD; et al.
JAMA Dermatol. 2013;149(2):243-245. doi:10.1001/jamadermatol.2013.1073.

Review | 
April W. Armstrong, MD, MPH; Caitlin T. Harskamp, BA; Ehrin J. Armstrong, MD, MSc
JAMA Dermatol. 2013;149(1):84-91. doi:10.1001/2013.jamadermatol.406.

Study | 
Rahat S. Azfar, MD; Nicole M. Seminara, MD; Daniel B. Shin, BA; et al.
Arch Dermatol. 2012;148(9):995. doi:10.1001/archdermatol.2012.1401.

Study |  FREE
Abrar A. Qureshi, MD, MPH; Hyon K. Choi, MD, DrPH; Arathi R. Setty, MD, MPH; et al.
Arch Dermatol. 2009;145(4):379-382. doi:10.1001/archdermatol.2009.48.

Off-Center Fold | 
Ser Ling Chua, MRCP; Kusum Kulkarni, MRCPath; Eric Saihan, FRCP
Arch Dermatol. 2007;143(9):1201-1206. doi:10.1001/archderm.143.9.1201-a.

Off-Center Fold | 
Erin B. Lesesky, MD; Michelle T. Pelle, MD; Terence C. O’Grady, MD
Arch Dermatol. 2007;143(9):1201-1206. doi:10.1001/archderm.143.9.1201-c.

Off-Center Fold | 
Shanna B. Meads, MD; Frances I. Ramos-Ceballos, BS, BA; Francisco A. Ramos-Caro, MD
Arch Dermatol. 2005;141(11):1457-1462. doi:10.1001/archderm.141.11.1457-c.

Study |  FREE
Wynnis L. Tom, MD; David H. Peng, MD, MPH; Atabak Allaei, BS; et al.
Arch Dermatol. 2005;141(11):1373-1377. doi:10.1001/archderm.141.11.1373.

The Cutting Edge |  FREE
Michelle T. Pelle, MD; O. Fred Miller III, MD
Arch Dermatol. 2001;137(10):1288-1290. doi:10.1001/archderm.137.10.1288.

Off-Center Fold | 
Samuel L. Gettler, BA; Maxwell A. Fung, MD
Arch Dermatol. 2001;137(7):957-962. doi:.

Off-Center Fold | 
Toby A. Chave, MRCP; Sandeep Varma, MRCP; Jennifer M. J. Logan, MRCP; et al.
Arch Dermatol. 2001;137(6):815-820. doi:.

Correspondence | 
James F. Libecco, BS; Robert T. Brodell, MD
Arch Dermatol. 2001;137(4):510-511. doi:.

Observation |  FREE
Gil Yosipovitch, MD; Baruch Mevorah, MD; Michael David, MD; et al.
Arch Dermatol. 1999;135(10):1237-1242. doi:10.1001/archderm.135.10.1237.

Off-Center Fold | 
Robert Huff; Scott Fretzin, MD; Charles Lewis, MD
Arch Dermatol. 1999;135(7):845-850. doi:10-1001/pubs.Arch Dermatol.-ISSN-8503-987x-135-7-dof0799.

Off-Center Fold | 
Arch Dermatol. 1999;135(7):845-850. doi:10-1001/pubs.Arch Dermatol.-ISSN-8503-987x-135-7-dof0799.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Correction  | 
Error in Table in: Communication and Medication Refill Adherence: The Diabetes Study of Northern California

JAMA Internal Medicine
Viewpoint  | 
Nullius In Verba:  Don't Take Anyone's Word for It
Richard S. Lehman, MA, BM,  BCh, MRCGP
JAMA Internal Medicine
Original Investigation  | 
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Internal Medicine
Invited Commentary  | 
Glucagonlike Peptide 1–Based Drugs and Pancreatitis:  Clarity at Last, but What About Pancreatic Cancer?
Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus”
Belinda Gier, PhD; Peter C. Butler, MD